Search research articles
Contact Us
Filters
Showing results (541-550 of 643) with videos related to
Page
of 65
Sort By:
Molecular Cancer Research : MCR
|
December 16, 2020
Molecular Profiling of Metastatic Bladder Cancer Early-Phase Clinical Trial Participants Predicts Patient Outcomes
Omar Alhalabi, Andrew W Hahn, Pavlos Msaouel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 20, 2022
Induction chemotherapy with or without erlotinib in patients with head and neck squamous cell carcinoma amenable for surgical resection
Xiuning Le, Frederico O Gleber-Netto, M Laura Rubin, et al.
Journal for Immunotherapy of Cancer
|
June 24, 2026
Artificial intelligence-guided analysis of the tumor microenvironment predicts response to pembrolizumab in rare tumors
Mohamed H Derbala, Bettzy Stephen, Woochan Hwang, et al.
NPJ Precision Oncology
|
July 27, 2025
IL-6 predicts CDK4/6 inhibitor resistance, identifying STAT3 as a target in HR + /HER2-negative metastatic breast cancer
Nicole M Kettner, Tuyen N Bui, Juliana Navarro-Yepes, et al.
ESMO Open
|
October 24, 2020
Responsiveness to immune checkpoint inhibitors versus other systemic therapies in RET-aberrant malignancies
Aparna Hegde, Alexander Y Andreev-Drakhlin, Jason Roszik, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
October 4, 2020
TRPS1: a highly sensitive and specific marker for breast carcinoma, especially for triple-negative breast cancer
Di Ai, Jun Yao, Fei Yang, et al.
Journal of the National Cancer Institute
|
July 16, 2026
Recurrence Score® gene group components and outcomes in the RxPONDER trial (SWOG S1007)
Yara Abdou, Jess Hoag, William E Barlow, et al.
Blood Advances
|
December 3, 2021
Epstein Barr virus-positive B-cell lymphoma is highly vulnerable to MDM2 inhibitors in vivo
Xiaoshan Zhang, Ran Zhang, Chenghui Ren, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 22, 2022
Natural History and Characteristics of ERBB2-mutated Hormone Receptor-positive Metastatic Breast Cancer: A Multi-institutional Retrospective Case-control Study from AACR Project GENIE
Michele L LeNoue-Newton, Sheau-Chiann Chen, Thomas Stricker, et al.
NPJ Precision Oncology
|
October 27, 2022
Challenges and opportunities associated with the MD Anderson IMPACT2 randomized study in precision oncology
Henry Hiep Vo, Siqing Fu, David S Hong, et al.
Page
of 65
Search research articles
Search
Showing results (541-550 of 643) with videos related to
Sort By:
Page
of 65
Molecular Cancer Research : MCR
|
December 16, 2020
Molecular Profiling of Metastatic Bladder Cancer Early-Phase Clinical Trial Participants Predicts Patient Outcomes
Omar Alhalabi, Andrew W Hahn, Pavlos Msaouel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 20, 2022
Induction chemotherapy with or without erlotinib in patients with head and neck squamous cell carcinoma amenable for surgical resection
Xiuning Le, Frederico O Gleber-Netto, M Laura Rubin, et al.
Journal for Immunotherapy of Cancer
|
June 24, 2026
Artificial intelligence-guided analysis of the tumor microenvironment predicts response to pembrolizumab in rare tumors
Mohamed H Derbala, Bettzy Stephen, Woochan Hwang, et al.
NPJ Precision Oncology
|
July 27, 2025
IL-6 predicts CDK4/6 inhibitor resistance, identifying STAT3 as a target in HR + /HER2-negative metastatic breast cancer
Nicole M Kettner, Tuyen N Bui, Juliana Navarro-Yepes, et al.
ESMO Open
|
October 24, 2020
Responsiveness to immune checkpoint inhibitors versus other systemic therapies in RET-aberrant malignancies
Aparna Hegde, Alexander Y Andreev-Drakhlin, Jason Roszik, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
October 4, 2020
TRPS1: a highly sensitive and specific marker for breast carcinoma, especially for triple-negative breast cancer
Di Ai, Jun Yao, Fei Yang, et al.
Journal of the National Cancer Institute
|
July 16, 2026
Recurrence Score® gene group components and outcomes in the RxPONDER trial (SWOG S1007)
Yara Abdou, Jess Hoag, William E Barlow, et al.
Blood Advances
|
December 3, 2021
Epstein Barr virus-positive B-cell lymphoma is highly vulnerable to MDM2 inhibitors in vivo
Xiaoshan Zhang, Ran Zhang, Chenghui Ren, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 22, 2022
Natural History and Characteristics of ERBB2-mutated Hormone Receptor-positive Metastatic Breast Cancer: A Multi-institutional Retrospective Case-control Study from AACR Project GENIE
Michele L LeNoue-Newton, Sheau-Chiann Chen, Thomas Stricker, et al.
NPJ Precision Oncology
|
October 27, 2022
Challenges and opportunities associated with the MD Anderson IMPACT2 randomized study in precision oncology
Henry Hiep Vo, Siqing Fu, David S Hong, et al.
Page
of 65